Altre lingue Artrya Limited

Azioni

AYA

AU0000182412

Tempo differito Australian S.E. Altri mercati azionari 04:06:06 23/05/2024			Variaz. 5gg	Var. 1 gen.
0,26 ^AUD	0,00%		-7,14%	+8,33%

02/04	Artrya firma un accordo commerciale per la tecnologia diagnostica delle malattie cardiache; le azioni salgono dell'8%.	MT
12/03	Artrya si prepara al lancio negli Stati Uniti dopo la partnership con Tanner Health System	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Artrya Signs Commercial Agreement for Heart Disease Diagnostic Technology; Shares Up 8%	02/04
Artrya Gears Up for US Launch After Tanner Health System Partnership	12/03
Artrya Limited Reports Earnings Results for the Six Months Ended December 31, 2023	28/02
Weekly Top Ten News Stories - 23 February 2024	23/02
12,000,000 Options of Artrya Limited are subject to a Lock-Up Agreement Ending on 26-NOV-2023.	26/11
15,610,470 Ordinary Shares of Artrya Limited are subject to a Lock-Up Agreement Ending on 26-NOV-2023.	26/11
Artrya Enters US Market Via Strategic Commercial Partnership	20/11
Artrya Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Artrya Completes Q-Submission Meeting with US FDA for Salix Product	12/06/23
Worries of Rate Hike Drag on Financial Markets Send Australian Shares into Losses	03/05/23
Artrya Completes Key Step for US Regulatory Approval of Coronary Artery Software	03/05/23
John Barrington AM to Step Down from the Board and Resign as Managing Director of Artrya Limited	27/03/23
Artrya Limited Announces CEO Changes	27/03/23
Artrya Limited Announces Board Changes	22/02/23
Artrya Limited Reports Earnings Results for the Half Year Ended December 31, 2022	21/02/23
Artrya Obtains UK Regulatory Approval for Salix Coronary Anatomy Product	07/11/22
Artrya Limited Gains UK Regulatory Approval for its Salix Coronary Anatomy Product	07/11/22
Artrya Secures EU Approval for Coronary Analysis Product	28/10/22
Artrya Limited Receives Regulatory Approval for Its Salix Coronary Anatomy Product in Europe	27/10/22
Artrya Limited Announces Executive Changes	07/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Artrya Limited

Azioni

AYA

AU0000182412

Altre lingue

Filtri